In cases where the data is submitted to a regulator and is approved, the medicine will be granted a licence extension for that use as a new treatment indication."xiiLetter from the Association of the British Pharmaceutical Industry on Supply and Demand for Medicines following 21 January 2020 meeting, 26 February 2020...